TY - JOUR
T1 - Skin toxicity following radiotherapy in patients with breast carcinoma: is anthocyanin supplementation beneficial?
AU - Bracone, Francesca
AU - De Curtis, Amalia
AU - Di Castelnuovo, Augusto
AU - Pilu, Roberto
AU - Boccardi, Mariangela
AU - Cilla, Savino
AU - Macchia, Gabriella
AU - Deodato, Francesco
AU - Costanzo, Simona
AU - Iacoviello, Licia
AU - De Gaetano, Giovanni
AU - Morganti, Alessio Giuseppe
AU - Petroni, Katia
AU - Tonelli, Chiara
AU - Donati, Maria Benedetta
AU - Cerletti, Chiara
PY - 2021
Y1 - 2021
N2 - Background: The EU-supported ATHENA project stems from a previous study suggesting that moderate wine consumption reduced the side-effects of radiotherapy (RT) in breast cancer patients, an effect possibly due to non-alcoholic anthocyanin fractions of wine. Objective: To evaluate the role of anthocyanins on RT skin side effects in breast cancer patients. Methods: Randomized, controlled, double-blind clinical trial. Patients were assigned to an intensity modulated radiation therapy (IMRT) either for three or five weeks, then randomized to receive three times a day a water-soluble anthocyanin (125 mg)-rich extract of corn cob or a placebo. Supplementation started one week before till the end of RT. Skin characteristics were detected by a standardized, non-invasive Cutometer® dual-MPA580, providing quantitative indices of skin maximal distensibility (R0), elasticity (R2, R5, R7) and viscoelasticity (R6); a Mexameter® MX18 probe evaluated the skin erythema (Er) and melanin (M). Measures were performed before (T0), at the end of RT and of supplementation (T1), and 1, 6 and 12 months after RT (T2-T4). Acute and late skin toxicity were scored according to the RTOG/EORTG scale. Selected biomarkers were measured at T0 and T1. Results: 193 patients previously assigned to 3- or 5-week RT schedules were randomized to either anthocyanin (97) or placebo (96) supplementation. RT induced changes in skin parameters: R0, R2, R5 and R7 decreased, while R6 increased; the changes in R0 and R6 continued in the same direction up to one year, while the others recovered towards basal values; Er and M peaked at T1 and T2, respectively, and returned to basal values at T4. Comparable skin changes were apparent in anthocyanin and placebo groups. A moderate RT-induced increase in total and HDL cholesterol and triglycerides was prevented by anthocyanins. Conclusions: Anthocyanin supplementation did not prevent RT-induced local skin toxicity. The supplementation was well tolerated and safe.
AB - Background: The EU-supported ATHENA project stems from a previous study suggesting that moderate wine consumption reduced the side-effects of radiotherapy (RT) in breast cancer patients, an effect possibly due to non-alcoholic anthocyanin fractions of wine. Objective: To evaluate the role of anthocyanins on RT skin side effects in breast cancer patients. Methods: Randomized, controlled, double-blind clinical trial. Patients were assigned to an intensity modulated radiation therapy (IMRT) either for three or five weeks, then randomized to receive three times a day a water-soluble anthocyanin (125 mg)-rich extract of corn cob or a placebo. Supplementation started one week before till the end of RT. Skin characteristics were detected by a standardized, non-invasive Cutometer® dual-MPA580, providing quantitative indices of skin maximal distensibility (R0), elasticity (R2, R5, R7) and viscoelasticity (R6); a Mexameter® MX18 probe evaluated the skin erythema (Er) and melanin (M). Measures were performed before (T0), at the end of RT and of supplementation (T1), and 1, 6 and 12 months after RT (T2-T4). Acute and late skin toxicity were scored according to the RTOG/EORTG scale. Selected biomarkers were measured at T0 and T1. Results: 193 patients previously assigned to 3- or 5-week RT schedules were randomized to either anthocyanin (97) or placebo (96) supplementation. RT induced changes in skin parameters: R0, R2, R5 and R7 decreased, while R6 increased; the changes in R0 and R6 continued in the same direction up to one year, while the others recovered towards basal values; Er and M peaked at T1 and T2, respectively, and returned to basal values at T4. Comparable skin changes were apparent in anthocyanin and placebo groups. A moderate RT-induced increase in total and HDL cholesterol and triglycerides was prevented by anthocyanins. Conclusions: Anthocyanin supplementation did not prevent RT-induced local skin toxicity. The supplementation was well tolerated and safe.
KW - Anthocyanin
KW - Cutometer-mexameter
KW - Skin toxicity
KW - Lipids
KW - Radiotherapy
KW - Inflammation
KW - Anthocyanin
KW - Cutometer-mexameter
KW - Skin toxicity
KW - Lipids
KW - Radiotherapy
KW - Inflammation
UR - http://hdl.handle.net/10807/303486
U2 - 10.1016/j.clnu.2020.09.030
DO - 10.1016/j.clnu.2020.09.030
M3 - Article
SN - 0261-5614
VL - 40
SP - 2068
EP - 2077
JO - Clinical Nutrition
JF - Clinical Nutrition
ER -